Vimarsana
Biggest News Aggregation in the World

Page 34 - Group Information News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Group Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Group Information Today - Breaking & Trending Today

Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection - Vimarsana News

Cefepime vs Piperacillin-Tazobactam in Adults Hospitalized With Acute Infection

This randomized clinical trial compares the use of cefepime vs piperacillin-tazobactam and the risk of acute kidney injury and neurological dysfunction in adult

Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury - Vimarsana News

Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury

This clinical trial examines whether early, empirical, high-dose cryoprecipitate, in addition to standard major hemorrhage protocols, would improve survival in

Red Blood Cell Transfusion in the Intensive Care Unit - Vimarsana News

Red Blood Cell Transfusion in the Intensive Care Unit

This cohort study evaluates and describes red blood cell transfusion practices in intensive care units worldwide.

Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy - Vimarsana News

Eplontersen for Hereditary Transthyretin Amyloidosis With Polyneuropathy

This open-label, single-group, phase 3 trial evaluates eplontersen, an investigational ligand-conjugated antisense oligonucleotide, in adults with hereditary am

Nippon Sanso Holdings Corporation: Publication of "Integrated Report 2023" | Business - Vimarsana News

Nippon Sanso Holdings Corporation: Publication of "Integrated Report 2023" | Business

TOKYO--(BUSINESS WIRE)--Sep 26, 2023--